Banque Pictet & Cie Sa Incyte Corp Transaction History

Banque Pictet & Cie Sa

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$60.95 - $75.51 $205,523 - $254,619	-3,372 Reduced 34.49%	6,405 $398,000
Q1 2023 May 01, 2023	BUY	$70.23 - $86.01 $80,694 - $98,825	1,149 Added 13.32%	9,777 $706,000
Q4 2022 Feb 06, 2023	SELL	$67.18 - $84.11 $445,873 - $558,238	-6,637 Reduced 43.48%	8,628 $0
Q3 2022 Nov 10, 2022	BUY	$66.18 - $82.86 $1.01 Million - $1.26 Million	15,265 New	15,265 $1.02 Billion

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

Stay updated on Banque Pictet & Cie Sa with notifications on news.